What MABVAX THERAPEUTICS HOLDINGS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Varvaro Thomas C | Director | Apr 03 | Exercise / conversion · M | +513 | — | — | 23,063 |
| Maier Paul V | Director | Apr 02 | Exercise / conversion · M | +513 | — | — | 23,063 |
| Hansen John David | PRESIDENT AND CEO | Apr 02 | Withheld — tax / exercise cost · F | −4,689 | — | — | 190,827 |
| Hansen John David | PRESIDENT AND CEO | Apr 02 | Exercise / conversion · M | +13,561 | — | — | 195,516 |
| Hanson Gregory P | CHIEF FINANCIAL OFFICER, SECR | Apr 02 | Withheld — tax / exercise cost · F | −2,428 | — | — | 114,307 |
| Hanson Gregory P | CHIEF FINANCIAL OFFICER, SECR | Apr 02 | Exercise / conversion · M | +7,021 | — | — | 116,735 |
| Maffuid Paul W | EXEC. VP, R AND D | Apr 02 | Withheld — tax / exercise cost · F | −1,735 | — | — | 99,877 |
| Maffuid Paul W | EXEC. VP, R AND D | Apr 02 | Exercise / conversion · M | +5,015 | — | — | 101,612 |
| Cohen Kenneth M | Director | Apr 02 | Exercise / conversion · M | +513 | — | — | 24,552 |
| Maier Paul V | Director | Jan 24 | Open-market sale · S | −17,999 | $0.84 | −$15.1K | 68,314 |
| Eisenberg Jeffrey F | Director | Jan 24 | Open-market sale · S | −17,998 | $0.84 | −$15.1K | 64,558 |
| Varvaro Thomas C | Director | Jan 24 | Open-market sale · S | −17,996 | $0.84 | −$15.1K | 67,645 |
| Cohen Kenneth M | Director | Jan 24 | Open-market sale · S | −17,996 | $0.84 | −$15.1K | 78,355 |
| Maier Paul V | Director | Jan 23 | Open-market sale · S | −17,449 | $0.87 | −$15.2K | 86,313 |
| Eisenberg Jeffrey F | Director | Jan 23 | Open-market sale · S | −17,444 | $0.87 | −$15.2K | 82,556 |
| Varvaro Thomas C | Director | Jan 23 | Open-market sale · S | −17,445 | $0.87 | −$15.2K | 85,641 |
| Cohen Kenneth M | Director | Jan 23 | Open-market sale · S | −17,444 | $0.87 | −$15.2K | 96,351 |
| Hansen John David | PRESIDENT AND CEO | Jan 16 | Open-market sale · S | −59,263 | $0.92 | −$54.5K | 536,730 |
| Hanson Gregory P | CHIEF FINANCIAL OFFICER, SECR | Jan 16 | Open-market sale · S | −41,873 | $0.92 | −$38.5K | 320,013 |
| Resnick Paul F | VICE PRESIDENT, CBO | Jan 16 | Open-market sale · S | −3,071 | $0.92 | −$2.83K | 18,333 |
Loading...